Utah Medical Products, Inc. (NASDAQ:UTMD) Shares Sold by Rice Hall James & Associates LLC

Rice Hall James & Associates LLC decreased its position in shares of Utah Medical Products, Inc. (NASDAQ:UTMD - Free Report) by 5.4% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 78,808 shares of the medical instruments supplier's stock after selling 4,530 shares during the period. Rice Hall James & Associates LLC owned 2.32% of Utah Medical Products worth $4,844,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of UTMD. Hotchkis & Wiley Capital Management LLC lifted its stake in shares of Utah Medical Products by 128.3% during the third quarter. Hotchkis & Wiley Capital Management LLC now owns 89,010 shares of the medical instruments supplier's stock valued at $5,956,000 after buying an additional 50,030 shares during the period. Minerva Advisors LLC increased its position in Utah Medical Products by 461.8% during the third quarter. Minerva Advisors LLC now owns 42,328 shares of the medical instruments supplier's stock worth $2,818,000 after purchasing an additional 34,794 shares during the last quarter. Victory Capital Management Inc. increased its position in Utah Medical Products by 439.0% during the third quarter. Victory Capital Management Inc. now owns 14,408 shares of the medical instruments supplier's stock worth $964,000 after purchasing an additional 11,735 shares during the last quarter. Allspring Global Investments Holdings LLC increased its position in Utah Medical Products by 838.8% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 11,698 shares of the medical instruments supplier's stock worth $719,000 after purchasing an additional 10,452 shares during the last quarter. Finally, Geode Capital Management LLC increased its position in Utah Medical Products by 9.6% during the third quarter. Geode Capital Management LLC now owns 97,080 shares of the medical instruments supplier's stock worth $6,497,000 after purchasing an additional 8,516 shares during the last quarter. Hedge funds and other institutional investors own 69.60% of the company's stock.

Analyst Ratings Changes

Separately, StockNews.com lowered shares of Utah Medical Products from a "strong-buy" rating to a "buy" rating in a research report on Thursday, November 7th.

Utah Medical Products Price Performance

UTMD stock traded down $0.57 on Friday, hitting $60.20. 14,923 shares of the company were exchanged, compared to its average volume of 23,401. Utah Medical Products, Inc. has a twelve month low of $58.87 and a twelve month high of $77.33. The business's fifty day moving average is $61.48 and its two-hundred day moving average is $64.47. The stock has a market capitalization of $204.08 million, a price-to-earnings ratio of 15.24 and a beta of 0.08.

Utah Medical Products (NASDAQ:UTMD - Get Free Report) last released its quarterly earnings data on Tuesday, January 28th. The medical instruments supplier reported $0.86 earnings per share (EPS) for the quarter. Utah Medical Products had a net margin of 33.92% and a return on equity of 11.07%.

Utah Medical Products Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, April 3rd. Stockholders of record on Friday, March 14th will be given a $0.305 dividend. This represents a $1.22 annualized dividend and a dividend yield of 2.03%. The ex-dividend date of this dividend is Friday, March 14th. Utah Medical Products's payout ratio is currently 30.89%.

Utah Medical Products Profile

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.